No. 8 2024 Q1 EBITDA on par with expectations

Udgivet den 02-05-2024  |  kl. 05:58  |  

Q1 revenue and EBITDA are in line with our expectations. We confirm our 2024 EBITDA guidance of DKK 600m.

CEO Jens Andersen says:
As expected, all segments showed negative growth in Q1 2024, with March performing slightly better than January and February.

In April, Solar Danmark's growth almost edged into positive territory. As a result of Solar Danmark winning more projects compared to the same period last year, we remain confident this positive development will continue for the rest of 2024.

Consequently, we confirm our 2024 EBITDA guidance of DKK 600m."

Q1 key financial messages

Q1 EBITDA is on par with expectations.Net working capital at the end of the quarter continued to fall.2024 EBITDA guidance of DKK 600m confirmed.


Adjusted organic growth reflects an adjustment for the early timing of Easter when compared to Q1 2023. However, the effect from the working days leading up to Easter, which traditionally see lower business activities, has not been adjusted in the organic growth.

Financial highlights (DKK million) Q1 2024 Q1 2023
Revenue 3,030 3,656
EBITDA 88 280
Cash flow from operating activities 7 101
Financial ratios (%)    
Organic growth adj. for number of working days -15.4 6.7
EBITDA margin 2.9 7.7
Net working capital, end of period/revenue (LTM) 15.1 16.7
Gearing (NIBD/EBITDA), no. of times 2.1 1.3
Return on invested capital (ROIC) 8.5 23.2


Guidance
We confirm our revenue guidance of DKK 12,500m and EBITDA guidance of DKK 600m.

General assumption
Our 2024 guidance is still impacted by an unpredictable market outlook due to heightened geopolitical and macroeconomic tension. However, we expect a recovery in the macroeconomic situation towards the end of the year.

We have implemented, and will continue to implement, mitigating measures, including cost containment, process improvements and the necessary staff reductions.

Audio webcast and teleconference today
The presentation of Quarterly Report Q1 2024 will be made in English on 2 May 2024 at 11:00 CET. The presentation will be transmitted as an audio webcast and will be available at www.solar.eu. Participation will be possible via teleconference.

Access to the webcast:
https://edge.media-server.com/mmc/p/acg7dj7n

To participate by telephone, and thus have the possibility to ask questions:
Register in advance of the teleconference using the link below. Upon registering, each participant will be provided with a Dial In Number, and a unique Personal PIN:
https://register.vevent.com/register/BI4beb31a6765242ba8fa435a1e948423f

Contacts
CEO Jens Andersen - tel. +45 79 30 02 01
CFO Michael H. Jeppesen - tel. +45 79 30 02 62
IR Director Dennis Callesen - tel. +45 29 92 18 11

 

Facts about Solar

Solar is a leading European sourcing and services company mainly within electrical, heating and plumbing, ventilation and climate and energy solutions. Our core business centres on product sourcing, value-adding services and optimisation of our customers' businesses.

We facilitate efficiency improvement and provide digital tools that turn our customers into winners. We drive the green transition and provide best in class solutions to ensure sustainable use of resources.

Solar Group is headquartered in Denmark, generated revenue of approx. DKK 13.0bn in 2023 and has approx. 3,000 employees. Solar is listed on Nasdaq Copenhagen and operates under the short designation SOLAR B. For more information, please visit www.solar.eu.

Disclaimer
This announcement was published in Danish and English today via Nasdaq Copenhagen. In the event of any inconsistency between the two versions, the Danish version shall prevail.

 

Attachments

No. 8 2024 Quarterly Report Q1 2024 Solar Quarterly Report Q1 2024 SOLA-2024-03-31-en

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

12:05 Genmab falder tungt: Overreaktion på manglende wow-effekt mener Jyske Bank
11:56 ISS forlænger kæmpekontrakt med Barclays
11:44 Aktier/middag: Zealand og Genmab synkers til bunds mens Mærsk stiger efter ratetal
11:42 Genmab falder tungt: Overreaktion på manglende wow-effekt mener Jyske Bank
09:52 Aquaporin er nu meget mere attraktiv som investering mener storbank
09:22 Aktier/åbning: Zealand Pharma i pænt dyk efter data - Mærsk stiger på ratetal
09:19 Mærsk nyder godt af fortsatte ratestigninger: Priser er steget 39 pct. på tre uger
08:47 Obligationer/åbning: Rolig start efter turbulent torsdag - centralbanktaler i fokus
08:23 Tysk økonomi vokser i første kvartal - sunder sig efter sløjt 2023
08:22 Dansk erhvervstillid rammer højeste niveau siden april 2022
08:00 Virksomhederne forventer stigende beskæftigelse
07:55 Aquaporin er nu meget mere attraktiv som investering mener storbank
07:44 Aktier/tendens: Novo, Mærsk og Zealand Pharma i fokus i ventet rød start
07:40 Aarsleff på vej med trecifret millionudlodning, forudser Danske Bank
07:35 Råvarer: Oliepriserne er stabile trods usikre renteudsigter
07:00 Coloplast får trimmet kursmålet hos canadisk finanshus
06:48 Obligationer/tendens: Vigende rente i sigte på svindende håb om rentesænkning i USA
06:43 Et rederi skiller sig ud i blandet fredagsmarked for Mærsks asiatiske konkurrenter
06:37 Asien: Røde markeder over alt efter dyk på Wall Street
06:35 Zealand Pharma viser pæne vægttab med lave doser af kandidat i tidligt studie